转染技术市场 - 副产品（试剂盒和试剂、设备）、方法（物理转染、基于生化的转染）、应用（治疗交付、生物医学研究）、最终用途 - 全球预测（2024 - 2032）

Transfection Technologies Market - By Product (Kits and Reagents, Equipment), Method (Physical Transfection, Biochemical-based Transfection), Application (Therapeutic Delivery, Biomedical Research), End-use - Global Forecast (2024 - 2032)

出版日期: 2024年04月18日 | 出版商:

Global Market Insights Inc. | 英文 201 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在基因治疗、基因研究和生物製药开发进步的推动下，预计 2024 年至 2032 年转染技术市场的复合年增长率将达到 8.9%。转染技术有助于基因传递、细胞功能研究和治疗修饰。遗传疾病和癌症的盛行率日益增加，对有效基因治疗的需求激增，导致转染技术的研发强度增加。根据泛美卫生组织估计，2023 年将有 2,000 万新发癌症病例和 1,000 万癌症死亡病例。递送方法。

製药和生物技术产业对开发新型生物製剂和个人化药物的关注也将影响市场成长。这些技术能够生产重组蛋白、单株抗体和基于细胞的疗法，这对于治疗各种疾病和病症至关重要。此外，非感染性输送系统和先进的抗生素製剂使感染控制系统更有效率、安全和可扩展，进一步扩大了其在研究和临床环境中的用途。

转染技术产业分为产品、方法、应用、最终用途和地区。

预计设备产品领域的市场价值将在 2024 年至 2032 年间出现显着的复合年增长率，这得益于提供提高效率和可扩展性的基本工具和系统的能力。先进的转染工具，例如微滤装置、显微注射系统和核转染平台，使研究人员和生物製药公司能够将基因传递到细胞。转换工具的持续创新，包括整合设计和工作流程，也简化了实验室操作，减少了实验变异性，并提高了可重复性。

从应用来看，由于科学认识和治疗开发的进步，生物医学研究领域的转染技术市场价值预计将在 2024 年至 2032 年期间显着增长。转染技术使研究人员能够将基因精确地插入细胞中，更容易研究基因功能、蛋白质表现和疾病。这种能力对于识别新的治疗标靶、验证候选药物以及临床前疗效和安全性评估非常重要。

预计到 2032 年，亚太地区转染技术产业将以复合年增长率大幅成长。不同年龄层的存在也为该地区生物技术公司和研究机构进行基因和细胞研究提供了重要机会。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Lonza
MaxCyte, Inc.
QIAGEN N.V.
Revvity, Inc.
Sartorius AG
Thermo Fisher Scientific, Inc.

简介目录

Product Code: 9113

Transfection technologies market is predicted to witness 8.9% CAGR from 2024 to 2032, driven by advancements in gene therapy, genetic research, and biopharmaceutical development. Transfection technology helps in gene delivery, the study of cell function and therapeutic modification. The increasing prevalence of genetic diseases and cancers has surged the demand for effective gene therapy, leading to higher R&D efforts in transfection technologies. As per Pan America Health Organization, it was estimated that there were 20 million new cases of cancer and 10 million cancer deaths in 2023. The expanding use of gene editing techniques, such as CRISPR-Cas9 has stimulated the need for more precise and efficient gene delivery methods in target cells.

The focus of the pharmaceutical and biotechnology industries on developing novel biologics and personalized medicines will also influence the market growth. These technologies enable the production of recombinant proteins, monoclonal antibodies, and cell-based therapies, which are critical for treating various diseases and disorders. Additionally, non-infectious delivery systems and advanced antibiotic formulations are making infection control systems more efficient, safer, and scalable, further expanding their use in research and in clinical settings.

The transfection technologies industry is classified into product, method, application, end-use and region.

The market value from the equipment product segment is anticipated to observe a significant CAGR between 2024 and 2032 favored by the ability for providing essential tools and systems that enhance the efficiency and scalability. Advanced transfection tools, such as microfiltration devices, microinjection systems, and nucleotransfection platforms, allow researchers and biopharmaceutical companies to access gene delivery to cells. Continuous innovations in conversion tools, including integrated design and workflow is also simplifying laboratory operations, reducing experimental variability, and enhancing repeatability.

Based on application, the transfection technologies market value from the biomedical research segment is set to witness notable growth during 2024-2032 due to advances in scientific understanding and therapeutic development. Transfection technology allows researchers to precisely insert genes into cells, making it easier to study gene function, protein expression and diseases. This capability is important for the identification of novel therapeutic targets, the validation of drug candidates, and the preclinical evaluation of efficacy and safety.

Asia Pacific transfection technologies industry is anticipated to grow at a substantial CAGR through 2032. This is attributed to the increasing investments in biotechnology and pharmaceutical research, the rising prevalence of chronic diseases, and expanding government initiatives for supporting healthcare innovation. The presence of diverse age groups are also presenting significant opportunities for biotechnology companies and research institutes for gene- and cell-based research in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic diseases
  - 3.2.1.2 Rise in research and development in the field of cell-based therapies
  - 3.2.1.3 Technological advancement
  - 3.2.1.4 Expanded applications of transfection technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of transfection technology instruments
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Kits and reagents
5.3 Equipment

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Physical Transfection
- 6.2.1 Electroporation
- 6.2.2 Biolistic transfection/ gene guns
- 6.2.3 Microinjection
- 6.2.4 Other physical transfection methods
6.3 Biochemical-based transfection
- 6.3.1 Lipofection
- 6.3.2 Calcium phosphate transfection
- 6.3.3 Cationic polymer transfection
- 6.3.4 DEAE-dextran transfection
- 6.3.5 Magnet-assisted transfection
- 6.3.6 Dendrimer-mediated transfection
6.4 Viral-vector based transfection
6.5 Cotransfection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Therapeutic delivery
- 7.2.1 Biotherapeutics
- 7.2.2 Electroimmunotherapy
- 7.2.3 Electrochemotherapy
7.3 Biomedical research
- 7.3.1 Gene and protein expression studies
- 7.3.2 Cancer research
- 7.3.3 Transgenic models
7.4 Protein production
7.5 Cell-based microarrays

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 CROs and CDMOs
8.4 Academic and research institutes
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa